Sign In
Buy MYL
$15.86
+0 (+0%)
At Close: May 27, 2022
Upjohn Finance B.V. -- Moody's assigns Baa3 first-time issuer ratings to Upjohn/Viatris; outlook stable
12:24am, Wednesday, 17'th Jun 2020
Moody's Investors Service ("Moody's") assigned first-time Baa3 long-term issuer ratings to Upjohn Inc. and Upjohn Finance B.V. (collectively, "Upjohn"), the mature branded business of Pfizer Inc. ("Pf
FDA Ends Hydroxychloroquine's Emergency Use for Coronavirus
01:54pm, Tuesday, 16'th Jun 2020
The FDA said that chloroquine and hydroxychloroquine are unlikely to prove effective in treating COVID-19 as the known benefits outweigh the risks.
FDA Revokes Emergency Use Status Of Hydroxychloroquine, Hyped By Trump For Coronavirus
07:20pm, Monday, 15'th Jun 2020
The FDA revoked emergency use of the malaria drug hydroxychloroquine for COVID-19 on Monday.What Happened: In March, President Donald Trump revealed he is taking hydroxychloroquine.Previously the drug
MEDIA-Pfizer-Backed Viatris Eyes Jumbo Bond Sale for Mylan Combination - Bloomberg
03:57pm, Monday, 15'th Jun 2020Glaxo (GSK) HIV Drug Tivicay Gets FDA Approval for Toddlers
03:03pm, Monday, 15'th Jun 2020
FDA approves Glaxo's (GSK) oral suspension formulation of its three-drug regimen for HIV, Tivicay, as a treatment for patients aged at least four weeks and weighing at least 3kg.
Mylan N.V. -- Moody's: Upcoming debt financing brings Mylan/Upjohn one step closer to Viatris creation
02:47pm, Monday, 15'th Jun 2020
Moody's Investors Service ("Moody's") commented that Upjohn Inc.'s ("Upjohn") announced new debt financing will bring the combination of Mylan NV ("Mylan") and Upjohn one step closer to completion. M
Is Pfizer Stock A Buy As It Charges Ahead With A Coronavirus Vaccine?
01:00pm, Monday, 15'th Jun 2020
Pfizer stock is struggling amid broader unease related to the coronavirus pandemic even as the pharmaceutical company works on a coronavirus vaccine and nears a generic drugs tie with Mylan.
Mapi Pharma Ltd., a privately held, fully integrated, late clinical stage biopharmaceutical company today announced an additional $20 million investment from Mylan in support of continued Phase 3 clin
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
09:01pm, Friday, 12'th Jun 2020
Here's some welcome news for diabetics dealing with the high price of insulin: The Food and Drug Administration has approved Mylan (NASDAQ: MYL) and Biocon's Semglee, which is essentially identical to
Mylan & Biocon's Semglee Wins FDA Approval for Diabetes
05:58pm, Friday, 12'th Jun 2020
Mylan (MYL) and partner Biocon gains FDA approval for diabetes treatment, Semglee.
The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
11:30am, Friday, 12'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 11) * ADC Therapeutics SA (NYSE: ADCT) * Applied Molecul
Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)
10:35pm, Thursday, 11'th Jun 2020
Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Semglee™ (in
Delaware Enhanced Global Dividend and Income Fund Announces Change to Portfolio Management Team
10:33pm, Thursday, 11'th Jun 2020
Today, Delaware Enhanced Global Dividend and Income Fund (NYSE: DEX) (the "Fund"), a New York Stock Exchange–listed closed-end fund trading under the symbol "DEX," announced that, effective June 11,
Mylan (MYL) Up 13.7% Since Last Earnings Report: Can It Continue?
03:30pm, Wednesday, 10'th Jun 2020
Mylan (MYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Drug Stocks That Could Soar in 2020
02:31pm, Wednesday, 10'th Jun 2020
Have extra cash to spare? These drug stocks are significantly undervalued and could make you wealthy in the long run.
